Cargando…

Feasibility of [(68)Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma

BACKGROUND: [(68)Ga]Ga-FAPI-46 is a novel positron emission tomography (PET) ligand that targets fibroblast activation protein (FAP) expression as FAP inhibitor (FAPI) and could already show promising results in several tumor entities. It could be demonstrated that an increased FAP expression correl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Unterrainer, Lena M., Lindner, Simon, Eismann, Lennert, Casuscelli, Jozefina, Gildehaus, Franz-Josef, Bui, Vinh Ngoc, Albert, Nathalie L., Holzgreve, Adrien, Beyer, Leonie, Todica, Andrei, Brendel, Matthias, Cyran, Clemens C., Karl, Alexander, Stief, Christian G., Ledderose, Stephan T., Unterrainer, Marcus, Bartenstein, Peter, Wenter, Vera, Kretschmer, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308618/ https://www.ncbi.nlm.nih.gov/pubmed/35325283 http://dx.doi.org/10.1007/s00259-022-05761-5

Ejemplares similares

(68)Ga-EMP-100 PET/CT—a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer
por: Unterrainer, Lena M., et al.
Publicado: (2022)

Total Tumor Volume on (18)F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with (225)Ac-PSMA-I&T
por: Unterrainer, Lena M., et al.
Publicado: (2022)

(68)Ga-EMP-100 PET/CT—a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma—first in-human biodistribution and imaging results
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Salvage lymph node dissection after (68)Ga-PSMA or (18)F-FEC PET/CT for nodal recurrence in prostate cancer patients
por: Herlemann, Annika, et al.
Publicado: (2017)

PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches
por: Bui, Vinh Ngoc, et al.
Publicado: (2023)

Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?
por: Rodler, Severin, et al.
Publicado: (2022)

Feasibility of Different Tumor Delineation Approaches for (18)F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder
por: Eismann, Lennert, et al.
Publicado: (2022)

Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial
por: Holzgreve, Adrien, et al.
Publicado: (2023)

Fully-automated production of [(68)Ga]Ga-FAPI-46 for clinical application
por: Spreckelmeyer, Sarah, et al.
Publicado: (2020)

[(68) Ga]Ga-FAPI uptake correlates with the state of chronic kidney disease
por: Conen, Patrick, et al.
Publicado: (2022)

Salvage PRRT with (177)Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival
por: Rudisile, S., et al.
Publicado: (2019)

First Clinical Experience With [(68)Ga]Ga-FAPI-46-PET/CT Versus [(18)F]F-FDG PET/CT for Nodal Staging in Cervical Cancer
por: Wegen, Simone, et al.
Publicado: (2023)

Pneumonia with Intense (68)Ga-FAPI Uptake Mimicking Metastasis on (68)Ga-FAPI PET/CT in a Patient with Rectal Cancer
por: Erol Fenercioğlu, Özge, et al.
Publicado: (2023)

Performance and Prospects of [(68)Ga]Ga-FAPI PET/CT Scans in Lung Cancer
por: Borgonje, Paula E., et al.
Publicado: (2022)

Fully automated radiosynthesis of [(68)Ga]Ga-FAPI-46 with cyclotron produced gallium
por: Rosenberg, Adam J., et al.
Publicado: (2023)

Automated Synthesis of [(68)Ga]Ga-FAPI-46 on a Scintomics GRP Synthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2023)

Localization of Pyelonephritis by (68)Ga-FAPI PET CT
por: Jagtap, Rajlaxmi Rangrao, et al.
Publicado: (2023)

Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment?
por: Unterrainer, Marcus, et al.
Publicado: (2017)

Response to (225)Ac-PSMA-I&T after failure of long-term (177)Lu-PSMA RLT in mCRPC
por: Ilhan, Harun, et al.
Publicado: (2020)

Comparison of [(68)Ga]Ga-DOTA-FAPI-04 and [(18)F]FDG Uptake in Esophageal Cancer
por: Liu, Huipan, et al.
Publicado: (2022)

Effects of the Minimal Extrathyroidal Extension on Early Response Rates after (Adjuvant) Initial Radioactive Iodine Therapy in PTC Patients
por: Ahmaddy, Freba, et al.
Publicado: (2020)

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy
por: Rogowski, Paul, et al.
Publicado: (2021)

In response to: Anatomy of (18)F-GE180, a failed radioligand for the TSPO protein
por: Albert, Nathalie L., et al.
Publicado: (2020)

Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer
por: Rodler, Severin, et al.
Publicado: (2022)

Dosimetry and optimal scan time of [(18)F]SiTATE-PET/CT in patients with neuroendocrine tumours
por: Beyer, Leonie, et al.
Publicado: (2021)

FAPI-04 Uptake in Healthy Tissues of Cancer Patients in (68)Ga-FAPI-04 PET/CT Imaging
por: Gündoğan, Cihan, et al.
Publicado: (2021)

Ga68-FAPI Imaging and Lu177-FAPI Therapy in a Case of Metastatic Solitary Fibrous Tumor
por: Luthra, Karuna, et al.
Publicado: (2023)

Detection of Splenic Tissue Using (99m)Tc-Labelled Denatured Red Blood Cells Scintigraphy—A Quantitative Single Center Analysis
por: Holzgreve, Adrien, et al.
Publicado: (2022)

The diagnostic challenge of coexistent sarcoidosis and thyroid cancer – a retrospective study
por: Wenter, Vera, et al.
Publicado: (2021)

Assessment of myocardial fibrosis in patients with systemic sclerosis using [(68)Ga]Ga-FAPI-04-PET-CT
por: Treutlein, Christoph, et al.
Publicado: (2022)

(68)Ga-FAPI-PET/CT in patients with various gynecological malignancies
por: Dendl, Katharina, et al.
Publicado: (2021)

(68)Ga-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of α(v)ß(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer
por: Kazmierczak, Philipp M., et al.
Publicado: (2016)

Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD
por: Zang, Jie, et al.
Publicado: (2022)

Fully Automated Production of [(68)Ga]GaFAPI-46 with Gallium-68 from Cyclotron Using Liquid Targets
por: Fonseca, Alexandra I., et al.
Publicado: (2023)

Automated synthesis of [(68)Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
por: Alfteimi, Ammar, et al.
Publicado: (2022)

(18)F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results
por: Mittlmeier, L. M., et al.
Publicado: (2020)

Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma
por: Wenter, Vera, et al.
Publicado: (2020)

Dynamic PET/CT Imaging of (68)Ga-FAPI-04 in Chinese Subjects
por: Wang, Shuailiang, et al.
Publicado: (2021)

Clinical Significance of Diffusely Increased Uptake of (68)Ga-FAPI in Thyroid Gland
por: Liu, Huipan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2vv7tp0ldgtc2ehj92jh06len3